amoxapine has been researched along with Basal Ganglia Diseases in 8 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
Excerpt | Relevance | Reference |
---|---|---|
"The case of a patient who developed the neuroleptic malignant syndrome following an overdose of amoxapine is presented." | 7.67 | Neuroleptic malignant syndrome following amoxapine overdose. ( Schwartz, HI; Taylor, NE, 1988) |
"The case of a patient who developed the neuroleptic malignant syndrome following an overdose of amoxapine is presented." | 3.67 | Neuroleptic malignant syndrome following amoxapine overdose. ( Schwartz, HI; Taylor, NE, 1988) |
"Amoxapine was associated with significant neuroleptic activity in plasma." | 2.65 | Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. ( Cohen, BM; Curren, FC; Falk, WE; Gelenberg, AJ; Hicks, RH; Lydiard, RB; McCormick, MG; Wojcik, JD, 1984) |
"This extrapyramidal syndrome has not previously been linked with this widely used antidepressant, and clinicians should be aware of the association." | 1.27 | A case of akinesia induced by amoxapine. ( Gammon, GD; Hansen, C, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sunderland, T | 1 |
Orsulak, PJ | 1 |
Cohen, BM | 2 |
Gelenberg, AJ | 1 |
Wojcik, JD | 1 |
Lydiard, RB | 1 |
McCormick, MG | 1 |
Falk, WE | 1 |
Hicks, RH | 1 |
Curren, FC | 1 |
Luna, OC | 1 |
Jayatilaka, A | 1 |
Walker, V | 1 |
Gammon, GD | 1 |
Hansen, C | 1 |
McKnight, MA | 1 |
Ross, DR | 1 |
Lipper, S | 1 |
Gaffney, GR | 1 |
Tune, LE | 1 |
Taylor, NE | 1 |
Schwartz, HI | 1 |
Price, WA | 1 |
1 trial available for amoxapine and Basal Ganglia Diseases
Article | Year |
---|---|
Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients.
Topics: Adolescent; Adult; Ambulatory Care; Amoxapine; Basal Ganglia Diseases; Clinical Trials as Topic; Dep | 1984 |
7 other studies available for amoxapine and Basal Ganglia Diseases
Article | Year |
---|---|
Amoxapine and neuroleptic side effects: a case report.
Topics: Amoxapine; Antipsychotic Agents; Basal Ganglia Diseases; Depressive Disorder; Dibenzoxazepines; Fema | 1983 |
Amoxapine and extrapyramidal symptoms.
Topics: Adult; Amoxapine; Basal Ganglia Diseases; Dibenzoxazepines; Humans; Male; Psychotic Disorders | 1984 |
A case of akinesia induced by amoxapine.
Topics: Akinetic Mutism; Amoxapine; Basal Ganglia Diseases; Depressive Disorder; Dibenzoxazepines; Female; H | 1984 |
Amoxapine and extrapyramidal symptoms.
Topics: Amoxapine; Basal Ganglia Diseases; Dibenzoxazepines; Female; Humans; Male; Middle Aged; Psychotic Di | 1984 |
Serum neuroleptic levels and extrapyramidal side effects in patients treated with amoxapine.
Topics: Adult; Amoxapine; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzoxazepines; Dose-Response Rela | 1985 |
Neuroleptic malignant syndrome following amoxapine overdose.
Topics: Adult; Amoxapine; Basal Ganglia Diseases; Catatonia; Diagnosis, Differential; Dibenzoxazepines; Fema | 1988 |
Amoxapine-induced extrapyramidal effects.
Topics: Adult; Amoxapine; Basal Ganglia Diseases; Dibenzoxazepines; Female; Humans; Male; Middle Aged | 1986 |